By mid-2026, the industry has officially entered the era of "Metabolic miRNA Therapy." This year, the focus is on a groundbreaking study involving miR-71, which has been shown to regulate mitochondrial stress pathways and prevent the spread of "Damage Signals" between cells. This innovation is a primary driver for the market, as it opens the door for new drugs that could treat age-related...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek